Latest news
A4M and the International Peptide Society Welcome PCAC Recommendations Supporting Inclusion of Six Reviewed Peptides on the 503A Bulk List - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 16:07:01 GMTFDA PCAC Recommends Six Peptides for the 503A Bulks List: What Compounding Pharmacies Need to Know - Buchanan Ingersoll & Rooney PCBuchanan Ingersoll & Rooney PC · Tue, 04 Aug 2026 15:33:20 GMTCompounded peptides: FDA advisory committee weighs 503A bulks eligibility - Vera HealthVera Health · Fri, 31 Jul 2026 14:08:01 GMTPublic Comment Closes on the FDA Plan to Permanently Bar Bulk Compounding of Semaglutide and Tirzepatide - Medical DailyMedical Daily · Fri, 31 Jul 2026 12:50:09 GMTVictory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances - TradingViewTradingView · Wed, 29 Jul 2026 12:00:00 GMTFDA Committee Supports Peptide Compounding: What Comes Next for Compounders, Telehealth Platforms, Med Spas and Others - The National Law ReviewThe National Law Review · Wed, 29 Jul 2026 07:00:00 GMTPSM submits comment supporting the continued exclusion of GLP-1s from the 503B Bulks List - Partnership for Safe MedicinesPartnership for Safe Medicines · Tue, 28 Jul 2026 22:59:35 GMT